← Evidence map

ReviewFrontiers in aging neuroscience2022

PINK1/Parkin Pathway Activation for Mitochondrial Quality Control - Which Is the Best Molecular Target for Therapy?

Laura F SilvianPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35754955